Hardesty Center for Clinical Research and Neuroscience
Tulsa, Oklahoma, 74136, United States
NCT Number: NCT05041959
This study is designed to find out how smoking affects the way the brain responds to pleasure and how this impacts smokers' behavior. Participants will complete three sessions. The first session will be a screening and training visit to determine final eligibility. Eligible participants will work with a researcher to develop brief scripts about times when they smoke and do other activities. Next, participants will attend two magnetic resonance imaging (MRI) scans - one after abstaining from smoking for 24 hours and the other after smoking as usual. After the second MRI, participants will answer questions on their phone every day for two weeks.
Looking for future studies?
Notify Me21 year–55 year
All sexes
Interventional
Not applicable
Tulsa, Oklahoma, 74136, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will abstain from smoking for 24 hours
Participants will continue smoking as usual (i.e. ad lib) in the day leading up to the scan and smoke one cigarette of their own brand immediately prior to scanning.
Time frame: Approximately 2-4 weeks
BOLD activation in brain reward network regions
Time frame: 2-4 weeks
Anticipated and experienced pleasure based on self-report ratings acquired each day during the EMA phase
University of Oklahoma
Other
Acronym: NicWith
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04429568
Behavior, Blood Coagulation Disorders
San Francisco, California, United States
View Trial DetailsNCT07366294
Behavior, Behavioral Symptoms
Malang, East Java, Indonesia
View Trial DetailsNCT05095779
Behavior, Chemically-Induced Disorders
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT01780038
Behavior, Chemically-Induced Disorders
Omaha, Nebraska, United States
View Trial Details